SIASUN(SZ:300024)2026-04-01 09:59Summary of UBTECH Robotics 2025 Results Conference Call Company Overview - Company: UBTECH Robotics (Ticker: 9880.HK) - Industry: Robotics, specifically focusing on humanoid robots Key Financial Highlights - Net Loss: Decreased by 37% year-over-year (YoY) to Rmb703 million, surpassing CitiE/Bloomberg consensus by 20% and 31% respectively [1] - Gross Profit Margin (GPM): Expanded by 9.0 percentage points YoY to 37.7%, exceeding CitiE's estimate of 30.1% and consensus estimate of 31.3% [1] - Humanoid Robot Revenue: Increased 22 times YoY to Rmb820 million (1,079 units), which is 61% higher than the estimate of Rmb508 million (725 units) [1] - Humanoid Robot GPM: Reached 54.6% in 2025, contributing Rmb448 million to total gross profit, a 15.7 times increase YoY, representing 59% of total gross profit [1] Market Reaction and Analyst Rating - Anticipated positive reaction in UBTECH's share price due to the strong performance across various metrics [1] - Analyst Rating: Reiterated "Buy" rating based on UBTECH's first-mover advantage in the humanoid robot industry [1] Future Guidance - UBTECH is expected to provide further updates on humanoid robot shipment guidance and development during the results briefing scheduled for April 1, 2026 [2] Valuation Metrics - Current Share Price: HK$85.40 - Target Price: HK$155.00, implying an expected share price return of 81.5% [3] Risks Identified - Potential downside risks include: 1. Weaker-than-expected revenue growth 2. Slower-than-expected humanoid robot development 3. Higher R&D costs leading to worse-than-expected profitability [16] Earnings Summary (2023-2027 Estimates) - 2023: Net Profit: -Rmb1,234 million, EPS: -Rmb3.050 - 2024: Net Profit: -Rmb1,124 million, EPS: -Rmb2.673 - 2025: Net Profit: -Rmb879 million, EPS: -Rmb1.930 - 2026: Net Profit: -Rmb405 million, EPS: -Rmb0.805 - 2027: Net Profit: -Rmb12 million, EPS: -Rmb0.024 [5] Conclusion UBTECH Robotics has demonstrated significant improvement in its financial performance for 2025, particularly in reducing net losses and increasing gross profit margins. The company is well-positioned in the humanoid robot market, with strong revenue growth and a positive outlook, although it faces several risks that could impact future performance.